Home

Vivo Ventures V, LLC

CIK 1399028 · last filed 2019-11-25

Vivo Ventures V, LLC is a corporate insider who has filed 18 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing shows the insider sold $287.2K of SLNO on Nov 25, 2019. Across all open-market trades the lifetime net is −$30.9M, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

7

Total Filings

18

Lifetime Open-Market Net

-$30.90M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SOLENO THERAPEUTICS INC (SLNO) Delisted 10%+ Owner 245,727 $53.01 $13.03M -$931.9K 3 2019-11-25
SOLENO THERAPEUTICS INC (SLNOW) Delisted 10%+ Owner 4,219,504 — — $6.00M 4 2018-08-09
SOLENO THERAPEUTICS INC (CAPNW) Delisted 10%+ Owner 179,260 — — $0 1 2017-04-14
Sagent Pharmaceuticals, Inc. (SGNT) Delisted 10%+ Owner 2,978,803 — — -$34.44M 2 2016-04-25
SOLENO THERAPEUTICS INC (CAPN.W) Delisted 10%+ Owner 6,922,123 — — $0 1 2016-02-09
Lite Strategy, Inc. (MEIP) Delisted 10%+ Owner 9,645 $3.20 $30.9K -$1.53M 5 2015-11-09
ALBIREO PHARMA, INC. (BIOD) Delisted 10%+ Owner 56,188 — — $0 1 2007-05-18

Recent Filings

18 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2019-11-25 SOLENO THERAPEUTICS INC (SLNO) Delisted Sell (S) −185,013 -$287.2K EDGAR
2019-11-20 SOLENO THERAPEUTICS INC (SLNO) Delisted Sell (S) −124,887 -$193.6K EDGAR
2019-11-15 SOLENO THERAPEUTICS INC (SLNO) Delisted Sell (S) −291,072 -$451.2K EDGAR
2018-08-09 SOLENO THERAPEUTICS INC (SLNOW) Delisted Other (J) +978,447 $3.33M EDGAR
2017-12-19 SOLENO THERAPEUTICS INC (SLNOW) Delisted Buy (P) +3,256,440 $6.00M EDGAR
2017-10-04 SOLENO THERAPEUTICS INC (SLNOW) Delisted Grant (A) +16,827 $8.8K EDGAR
2017-07-17 SOLENO THERAPEUTICS INC (SLNOW) Delisted Grant (A) +14,344 $8.7K EDGAR
2017-04-14 SOLENO THERAPEUTICS INC (CAPNW) Delisted Grant (A) +13,888 $8.7K EDGAR
2016-09-01 — U −9,041,292 -$196.65M
2016-04-25 Sagent Pharmaceuticals, Inc. (SGNT) Delisted Sell (S) −6,015 -$81.5K EDGAR
Showing 1–10 of 18
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.